InvestorsHub Logo
Followers 62
Posts 7557
Boards Moderated 1
Alias Born 01/02/2003

Re: None

Wednesday, 11/23/2022 8:05:25 AM

Wednesday, November 23, 2022 8:05:25 AM

Post# of 426487
In Q1 of 2023. I expect...
-a proxy vote to be sent to shareholders by Denner, pursuing control of the Amarin BOD
- an announcement by management that a fixed dose combo approval by the FDA is now being pursued
-an announcement that an approval of MND-2119 is being pursued
- an announcement that an AG of Vascepa is being pursued with the FDA
-an announcement that Amarin is having exploratory discussions about a sale of the company to a BP
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AMRN News